KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Amortization of Deferred Charges (2020 - 2024)

Guardant Health's Amortization of Deferred Charges history spans 5 years, with the latest figure at $646000.0 for Q4 2024.

  • For Q4 2024, Amortization of Deferred Charges changed 0.31% year-over-year to $646000.0; the TTM value through Dec 2024 reached $2.6 million, changed 0.23%, while the annual FY2024 figure was $2.6 million, 0.23% changed from the prior year.
  • Amortization of Deferred Charges for Q4 2024 was $646000.0 at Guardant Health, roughly flat from $645000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $4.7 million in Q4 2020 and bottomed at $640000.0 in Q3 2021.
  • The 5-year median for Amortization of Deferred Charges is $643000.0 (2022), against an average of $883411.8.
  • The largest annual shift saw Amortization of Deferred Charges crashed 86.42% in 2021 before it grew 0.31% in 2022.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $4.7 million in 2020, then plummeted by 86.42% to $642000.0 in 2021, then increased by 0.16% to $643000.0 in 2022, then rose by 0.16% to $644000.0 in 2023, then grew by 0.31% to $646000.0 in 2024.
  • Per Business Quant, the three most recent readings for GH's Amortization of Deferred Charges are $646000.0 (Q4 2024), $645000.0 (Q3 2024), and $645000.0 (Q2 2024).